Patents by Inventor Venky Ramakrishna

Venky Ramakrishna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
    Patent number: 9624300
    Abstract: Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antibodies.
    Type: Grant
    Filed: December 17, 2012
    Date of Patent: April 18, 2017
    Assignee: Celldex Therapeutics Inc.
    Inventors: Tibor Keler, Lizhen He, Venky Ramakrishna, Laura A. Vitale
  • ANTIBODY VACCINE CONJUGATES AND USES THEREFOR
    Publication number: 20160355593
    Abstract: The present invention provides novel antibody vaccine conjugates and methods of using the same to induce a cytotoxic T cell (CTL) response. In a particular, embodiment, the vaccine conjugate includes a human chorionic gonadotropin beta subunit (?hCG) antigen linked to an anti-mannose receptor (MR) antibody.
    Type: Application
    Filed: January 12, 2016
    Publication date: December 8, 2016
    Inventors: Tibor Keler, Michael Endres, Lizhen He, Venky Ramakrishna
  • Antibody vaccine conjugates and uses therefor
    Patent number: 9259459
    Abstract: The present invention provides novel antibody vaccine conjugates and methods of using the same to induce a cytotoxic T cell (CTL) response. In a particular, embodiment, the vaccine conjugate includes a human chorionic gonadotropin beta subunit (?hCG) antigen linked to an anti-mannose receptor (MR) antibody.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: February 16, 2016
    Assignee: Celldex Therapeutics Inc.
    Inventors: Tibor Keler, Michael Endres, Lizhen He, Venky Ramakrishna
  • Antibody vaccine conjugates and uses therefor
    Patent number: 9243064
    Abstract: The present invention provides novel antibody vaccine conjugates and methods of using the same to induce a cytotoxic T cell (CTL) response. In a particular, embodiment, the vaccine conjugate includes a human chorionic gonadotropin beta subunit (?hCG) antigen linked to an anti-mannose receptor (MR) antibody.
    Type: Grant
    Filed: January 30, 2004
    Date of Patent: January 26, 2016
    Assignee: Celldex Therapeutics Inc.
    Inventors: Tibor Keler, Michael Endres, Lizhen He, Venky Ramakrishna
  • Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
    Patent number: 8586720
    Abstract: Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antibodies.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: November 19, 2013
    Assignee: Celldex Therapeutics Inc.
    Inventors: Tibor Keler, Lizhen He, Venky Ramakrishna, Laura A. Vitale
  • Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
    Patent number: 8362214
    Abstract: Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antibodies.
    Type: Grant
    Filed: May 5, 2009
    Date of Patent: January 29, 2013
    Assignee: Celldex Therapeutics Inc.
    Inventors: Tibor Keler, Lizhen He, Venky Ramakrishna, Laura A. Vitale
  • ANTIBODIES THAT BIND HUMAN DENDRITIC AND EPITHELIAL CELL 205 (DEC-205)
    Publication number: 20120309031
    Abstract: Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed.
    Type: Application
    Filed: July 6, 2012
    Publication date: December 6, 2012
    Applicant: CELLDEX THERAPEUTICS INC.
    Inventors: Tibor KELER, Lizhen HE, Venky RAMAKRISHNA, Laura A. VITALE
  • Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
    Patent number: 8236318
    Abstract: Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antibodies.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: August 7, 2012
    Assignee: Celldex Therapeutics Inc.
    Inventors: Tibor Keler, Lizhen He, Venky Ramakrishna, Laura A. Vitale
  • Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer
    Publication number: 20110142919
    Abstract: The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer.
    Type: Application
    Filed: February 18, 2011
    Publication date: June 16, 2011
    Applicant: Immunotope, Inc.
    Inventors: Venky Ramakrishna, Mark M. Ross, Ramila Philip
  • Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
    Patent number: 7919467
    Abstract: The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: April 5, 2011
    Assignee: Immunotope, Inc.
    Inventors: Venky Ramakrishna, Mark M. Ross, Ramila Philip, Lorraine H. Keller
  • Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
    Publication number: 20100098704
    Abstract: Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antibodies.
    Type: Application
    Filed: May 5, 2009
    Publication date: April 22, 2010
    Applicant: Celldex Therapeutics Inc.
    Inventors: Tibor Keler, Lizhen He, Venky Ramakrishna, Laura A. Vitale
  • ANTIBODY VACCINE CONJUGATES AND USES THEREFOR
    Publication number: 20090324622
    Abstract: The present invention provides novel antibody vaccine conjugates and methods of using the same to induce a cytotoxic T cell (CTL) response. In a particular, embodiment, the vaccine conjugate includes a human chorionic gonadotropin beta subunit (?hCG) antigen linked to an anti-mannose receptor (MR) antibody.
    Type: Application
    Filed: July 2, 2009
    Publication date: December 31, 2009
    Inventors: Tibor KELER, Michael ENDRES, Lizhen HE, Venky RAMAKRISHNA
  • ANTIBODIES THAT BIND HUMAN DENDRITIC AND EPITHELIAL CELL 205 (DEC-205)
    Publication number: 20090175880
    Abstract: Isolated monoclonal antibodies which bind to human DEC-205 and related antibody-based compositions and molecules are disclosed.
    Type: Application
    Filed: November 7, 2008
    Publication date: July 9, 2009
    Applicant: CELLDEX THERAPEUTICS INC.
    Inventors: Tibor KELER, Lizhen HE, Venky RAMAKRISHNA, Laura A. VITALE
  • CYTOTOXIC T-LYMPHOCYTE-INDUCING IMMUNOGENS FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF CANCER
    Publication number: 20080207497
    Abstract: The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer.
    Type: Application
    Filed: June 23, 2006
    Publication date: August 28, 2008
    Applicant: Immunotope, Inc.
    Inventors: Venky Ramakrishna, Mark M. Ross, Ramila Philip, Lorraine H. Keller
  • Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
    Patent number: 7083789
    Abstract: The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer.
    Type: Grant
    Filed: December 4, 2001
    Date of Patent: August 1, 2006
    Assignee: Immunotope, Inc.
    Inventors: Venky Ramakrishna, Mark M. Ross, Ramila Philip
  • Antibody vaccine conjugates and uses therefor
    Publication number: 20050180983
    Abstract: The present invention provides novel antibody vaccine conjugates and methods of using the same to induce a cytotoxic T cell (CTL) response. In a particular, embodiment, the vaccine conjugate includes a human chorionic gonadotropin beta subunit (?hCG) antigen linked to an anti-mannose receptor (MR) antibody.
    Type: Application
    Filed: July 30, 2004
    Publication date: August 18, 2005
    Applicant: CELLDEX Therapeutics, Inc.
    Inventors: Tibor Keler, Michael Endres, Lizhen He, Venky Ramakrishna
  • Antibody vaccine conjugates and uses therefor
    Publication number: 20040248215
    Abstract: The present invention provides novel antibody vaccine conjugates and methods of using the same to induce a cytotoxic T cell (CTL) response. In a particular, embodiment, the vaccine conjugate includes a human chorionic gonadotropin beta subunit (&bgr;hCG) antigen linked to an anti-mannose receptor (MR) antibody.
    Type: Application
    Filed: January 30, 2004
    Publication date: December 9, 2004
    Applicant: MEDAREX, INC.
    Inventors: Tibor Keler, Michael Endres, Lizhen He, Venky Ramakrishna
  • Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
    Publication number: 20030165513
    Abstract: The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer.
    Type: Application
    Filed: December 4, 2001
    Publication date: September 4, 2003
    Inventors: Venky Ramakrishna, Mark M. Ross, Ramila Philip